Standard Contracts
EXECUTION VERSIONConfidential Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Both, ALVOTECH and STADA, are hereinafter sometimes collectively referred to as the “Parties”, and each may be referred to in singular as a “Party”.
First Amendment to the Agreement for [***] First Amendment (hereinafter referred to as “AMENDMENT”) to the Agreement for [***] dated 06.11.2019 (hereinafter referred to as “AGREEMENT”) This AMENDMENT is made by and mutually agreed by and between:...Agreement for [***] • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Now, in consideration with what precedes, the Parties hereby wish to modify the AGREEMENT by the present AMENDMENT, which shall become an integral part of the AGREEMENT.
EXECUTION VERSIONConfidentiality Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Both, ALVOTECH and STADA, are hereinafter sometimes collectively referred to as the “Parties”, and each may be referred to in singular as a “Party”.
Originally dated 14 December 2018, as amended and restated on 24 June 2021 ALVOTECH HOLDINGS S.A. as Issuer ALVOTECH HF. ALVOTECH GERMANY GMBH ALVOTECH HANNOVER GMBH ALVOTECH SWISS AG as Guarantors THE BONDHOLDERS NAMED HEREIN as Bondholders MADISON...Bond Instrument • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
THIS AMENDED AND RESTATED BOND INSTRUMENT was originally dated 14 December 2018, and is amended and restated by the Amendment and Restatement Deed (as defined below) and is made by way of deed by:
Dated 21 October 2020 Shareholders’ Agreement relating to Alvotech Holdings S.A. between Alvotech Holdings S.A. as the Company Aztiq Pharma Partners S.à r.l. Alvogen Lux Holdings S.à r.l. Fuji Pharma Co., Ltd. YAS Holding the Individual Investors the...Shareholders’ Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • England and Wales
Alvotech Holdings S.A. (the Company) and Alvotech Lux Holdings S.A.S. (TopCo) and Floki Holdings S.à r.l. (Floki Holdings) and the parties listed in Annex 2 hereto (the Shareholders) Alvotech BCA Framework AgreementShareholders Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • Luxembourg
First Amendment to the Agreement for [***] First Amendment (hereinafter referred to as “AMENDMENT”) to the Agreement for [***] dated 30.08.2019 (hereinafter referred to as “AGREEMENT”) This AMENDMENT is made by and mutually agreed by and between:...Agreement for [***] • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Now, in consideration with what precedes, the Parties hereby wish to modify the AGREEMENT by the present AMENDMENT, which shall become an integral part of the AGREEMENT.
ContractSecond Amendment • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].”
LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • New York
THIS LICENSE AND DEVELOPMENT AGREEMENT (“Agreement”) is entered into as of 5 August, 2020 (the “Effective Date”) by and between Alvotech Hf., a corporation organized under the laws of Iceland, having its principal place of business at Saemundargotu 15-19, 101, Reykjavik, Iceland (“Alvotech”) and Teva Pharmaceuticals International GmbH, a company organized under the laws of Switzerland, having its principal place of business at Schluselstrasse 12, Rapperswil–Jona 8645, Switzerland (“Teva”). Each party shall be referred to individually as a “Party” and collectively as “Parties”.
First Amendment to the Agreement for [***] First Amendment (hereinafter referred to as “AMENDMENT”) to the Agreement for [***] dated 06.11.2019 (hereinafter referred to as “AGREEMENT”) This AMENDMENT is made by and mutually agreed by and between:...Agreement for [***] • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Now, in consideration with what precedes, the Parties hereby wish to modify the AGREEMENT by the present AMENDMENT, which shall become an integral part of the AGREEMENT.
First Amendment to the Agreement for [***] First Amendment (hereinafter referred to as “AMENDMENT”) to the Agreement for [***] dated 06.11.2019 (hereinafter referred to as “AGREEMENT”) This AMENDMENT is made by and mutually agreed by and between:...Agreement for [***] • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Now, in consideration with what precedes, the Parties hereby wish to modify the AGREEMENT by the present AMENDMENT, which shall become an integral part of the AGREEMENT.
LEASE AGREEMENT in respect of part of Sæmundargata 15 - 19 BETWEEN FASTEIGNAFÉLAGIÐ SÆMUNDUR HF. (as Lessor) AND ALVOTECH HF. (as Lessee)Lease Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
SETTLEMENT AGREEMENT, RELEASE AND AMENDMENT TO LDASettlement Agreement, Release and Amendment to Lda • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • New York
This Settlement Agreement, Release and Amendment to LDA (this “Agreement”) is entered into as of June 28, 2021 (the “Amendment Effective Date”) by and between Teva Pharmaceuticals International GmbH, a company organized under the laws of Switzerland, having its principal place of business at Schluselstrasse 12, Rapperswil–Jona 8645, Switzerland (“Teva”), and Alvotech Hf., a corporation organized under the laws of Iceland, having its principal place of business at Saemundargotu 15-19, 101, Reykjavik, Iceland (“Alvotech”). Teva and Alvotech shall be referred to collectively as the “Parties” and individually as a “Party.”
PRODUCT SUPPLY AGREEMENTProduct Supply Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • New York
This Product Supply Agreement (this “Agreement”) is entered into as of August 5, 2020 (the “Effective Date”) by and between Alvotech Hf., a corporation organized under the laws of the Iceland, having its principal place of business at Saemundargotu 15-19, 101, Reykjavik, Iceland (“Alvotech”) and Teva Pharmaceuticals International GmbH, a company organized under the laws of Switzerland, having its principal place of business at Schlüsselstrasse 12, Rapperswil–Jona 8645, Switzerland (“Teva”). Each party shall be referred to individually as a “Party” and collectively as “Parties”.
FORM OF WARRANT ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENTWarrant Agreement • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • New York
This Assignment, Assumption and Amendment Agreement (this “Agreement”) is made as of [•], 2022, by and among Oaktree Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), Alvotech Lux Holdings S.A.S., a simplified joint stock company (société par actions simplifiée) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Company Register (Registre de Commerce et des Sociétés, Luxembourg) (the “RCS”) under number B258884 (“TopCo”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
First Amendment to the Agreement for [***] First Amendment (hereinafter referred to as “AMENDMENT”) to the Agreement for [***] dated 06.11.2019 (hereinafter referred to as “AGREEMENT”) This AMENDMENT is made by and mutually agreed by and between:...Agreement for [***] • December 20th, 2021 • Alvotech Lux Holdings S.A.S.
Now, in consideration with what precedes, the Parties hereby wish to modify the AGREEMENT by the present AMENDMENT, which shall become an integral part of the AGREEMENT.
